CD4 and uterine cervix neoplasm: The strengths of our study include: the use of histologically-confirmed cervical biopsies from precancerous lesions and invasive cancer, showing HPV distribution from cervical tumors from both unvaccinated HIV-1-positive and HIV-1-seronegative women and timely enumeration of CD4 cells in HIV-1-positive women.